IGC Pharma, Inc.
IGC
$0.29
$0.000.32%
AMEX
| 06/30/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.23% | -13.88% | -33.58% | -33.47% | 34.55% |
| Total Depreciation and Amortization | -3.45% | -15.60% | -8.44% | -8.44% | -1.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.72% | -175.93% | -29.72% | -29.72% | 59.84% |
| Change in Net Operating Assets | 475.00% | 83.29% | -27.36% | -27.80% | -1,038.46% |
| Cash from Operations | -10.38% | -48.54% | -92.74% | -92.74% | 44.57% |
| Capital Expenditure | -400.00% | -262.50% | 55.56% | 55.56% | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -103.28% | 2,825.00% | 2,825.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.34% | -182.46% | 22.97% | 22.97% | -92.21% |
| Cash from Investing | -49.41% | -164.48% | 508.45% | 508.45% | -36.54% |
| Total Debt Issued | 10.91% | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | -- | -- | 100.00% |
| Issuance of Common Stock | 1,094.25% | 265.14% | 5.84% | 5.84% | 132.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.66% | 265.45% | 5.71% | 5.71% | 133.33% |
| Foreign Exchange rate Adjustments | 80.00% | -80.00% | 1,150.00% | 1,150.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.89% | 1,228.57% | 175.38% | 175.38% | 93.96% |